Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC
Clinical trial NCT05200988 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05200988
- Sponsor
- The Netherlands Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-14
- Primary completion
- 2025-09-05
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.